Adenoid hypertrophy, is the pharyngeal tonsil hyperplasia caused, most cases of adenoid hypertrophy and upper respiratory tract infections, acute and chronic rhinitis and other triggers related. Pharmacological treatment can be applied nasal spray glucocorticoids, antihistamines or anti-leukotriene receptor antagonist drugs symptomatic treatment.
1. Nasal spray glucocorticoid: it is the first choice for acute and chronic rhinitis, and also the first line of clinical medication for adenoid hypertrophy. For children aged 3 years and above, mometasone furoate nasal spray can be chosen; for children aged 6 years and above, budesonide nasal spray can be chosen; for children aged 12 years and above, fluticasone propionate nasal spray can be chosen for symptomatic treatment.
2. Antihistamines or anti-leukotriene receptor antagonists: such as the second-generation antihistamine drug loratadine and other drugs; montelukast, belonging to the leukotriene receptor antagonist class of drugs, to alleviate adenoid hypertrophy has a certain efficacy.
Patients with adenoid hypertrophy are prone to acute rhinitis, influenza and acute tonsillitis in childhood, which leads to rapid adenoid hyperplasia due to recurrent episodes of the condition, so it is important to seek medical attention in a timely manner, and timely compliance with the doctor’s prescription of medication to alleviate the symptoms.